Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: A randomized, double-blind clinical trial

Nutrition and Cancer

Volumn 67, Issue 3, 2015, Pages 457-462

  Sommacal, Heloisa Martins ^a   Bersch, Vivian Pierri ^b   Vitola, Santo Pascoal ^a   Osvaldt, Alessandro Bersch ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ABDOMINAL ABSCESS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BIFIDOBACTERIUM BIFIDUM; BILE DUCT FISTULA; BLEEDING; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEART FAILURE; HUMAN; KIDNEY FAILURE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; LIVER DYSFUNCTION; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PANCREAS FISTULA; PERIAMPULLARY NEOPLASM; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RESPIRATORY FAILURE; RISK ASSESSMENT; SEPSIS; SMALL INTESTINE TUMOR; STOMACH EMPTYING; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT DURATION; URINARY TRACT INFECTION; WOUND DEHISCENCE; COMMON BILE DUCT NEOPLASMS; FEMALE; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL; VATER PAPILLA; VERY ELDERLY;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BIFIDUM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; SYNBIOTICS;

EID: 84926525061     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1004734     Document Type: Article

References (31)

1. Yadav D and Lowenfels AB: The epidemiology of pancreatitis and pancreatic cancer: An update. Gastroen 144, 1252-1261, 2013.
2. Vincent A, Herman J, Schulick R, Hruban RH, and Goggins M: Pancreatic cancer. Lancet 13, 607-620, 2011.
3. de Icaza E, Lopez-Cervantes M, Arredondo A, and Robles-Diaz G: Likelihood ratios of clinical, laboratory and image data of pancreatic cancer: Bayesian approach. J Eval Clin Pract 15, 62-68, 2009.
4. Veillette G, Dominguez I, Ferrone C, Thayer SP, McGrath D, et al.: Implications and management of pancreatic fistulas following pancreaticoduodenectomy: The Massachusetts General Hospital experience. Arch Surg 143, 476-481; 2008.
5. Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, et al.: Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 92 (1), 21-23; 2005.
6. Klein GL, Petschow BW, Shaw AL, Weaver E: Gut barrier dysfunction and microbial translocation in cancer cachexia: A new therapeutic target. Curr Opin Support Palliat Care 7, 361-367, 2013.
7. Guarner F and Malagelada JR: Gut flora in health and disease. Lancet 361, 512-519, 2003.
8. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, and Eleftheriadis E: Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: Early results of a randomized controlled trial. World J Surg 30, 1848-1855, 2006.
9. Naito S, Koga H, Yamaguchi A, Fujimoto N, Hasui Y, et al.: Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer. J Urol 179, 485-490, 2008.
10. Ruemmele FM, Bier D, Marteau P, Rechkemmer G, Bourdet-Sicard R, et al.: Clinical evidence for immunomodulatory effects of probiotic bacteria. J Pediatr Gastroenterol Nutr 48, 126-141, 2009.
11. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, et al.: Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10, 37-54, 2008.
12. Hardy H, Harris J, Lyon E, Beal J, and Foey AD: Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology. Nutrients 5, 1869-1912, 2013.
13. Balasubramanian SP, Wiener M, Alshameeri Z, Tiruvoipati R, Elbourne D, et al.: Standards of reporting of randomized controlled trials in general surgery: Can we do better? Ann Surg 244, 663-667, 2006.
14. Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, et al.: Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: A randomized, double-blind trial. Ann Surg 246, 36-41, 2007.
15. Nomura T, Tsuchiya Y, Nashimoto A, Yabusaki H, Takii Y, et al.: Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 54, 661-663, 2007.
16. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, et al.: Supply of pre-And probiotics reduces bacterial infection rates after liver transplantation-A randomized, double-blind trial. Am J Transplant 5, 125-130, 2005.
17. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, et al.: Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53, 1602-1609, 2004.
18. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, et al.: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: A randomized controlled trial. Ann Surg 244, 706-714, 2006.
19. Denipote FG, Trindade EB, and Burini RC: Probiotics and prebiotics in primary care for colon cancer. Arq Gastroenterol 47, 93-98, 2010.
20. Alberda C, Gramlich L, Meddings J, Field C, McCargar L, et al.: Effects of probiotic therapy in critically ill patients: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 85, 816-823, 2007.
21. Rayes N, Seehofer D, Muller AR, Hansen S, Bengmark S, et al.: Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery: results of a prospective trial. Z Gastroenterol 40, 869-876, 2002.
22. Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, et al.: Pancreaticoduodenectomy: A 20-year experience in 516 patients. Arch Surg 139, 718-725; discussion 25-27, 2004.
23. Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, et al.: Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol 18, 2126-2135, 2011.
24. Ramacciato G, Mercantini P, Petrucciani N, Nigri GR, Kazemi A, et al.: Risk factors of pancreatic fistula after pancreaticoduodenectomy: A collective review. Am Surg 77, 257-269, 2011.
25. Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, and Jaques DP: Defining morbidity after pancreaticoduodenectomy: Use of a prospective complication grading system. J Am Coll Surg 204, 356-364, 2007.
26. Balzano G, Zerbi A, Braga M, Rocchetti S, Beneduce AA, et al.: Fasttrack recovery programme after pancreatico-duodenectomy reduces delayed gastric emptying. Br J Surg 95, 1387-1393, 2008.
27. DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, et al.: Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 244, 931-937, discussion 7-9, 2006.
28. He J, Ahuja N, Makary AM, Cameron JL, Eckhauser FE, Cet al.: 2564 resected periampullary adenocarcinomas at a single institution: Trends over three decades. HPB 16, 83-90, 2014.
29. Khithani A, Christian D, Lowe K, Saad AJ, Linder JD, et al.: Feasibility of pancreaticoduodenectomy in a nonuniversity tertiary care center: What are the key elements of success? Am Surg 77, 545-551; 2011.
30. Baker MS, Bentrem DJ, Ujiki MB, Stocker S, and Talamonti MS.: Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg 201, 295-299; discussion 299-300, 2011.
31. Lavu H, Klinge MJ, Nowcid LJ, Cohn HE, Grenda DR, et al.: Perioperative surgical care bundle reduces pancreaticoduodenectomy wound infections. J Surg Res 174, 215-221, 2011.